Brain network changes in adults with anemia measured by fNIRS

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study will use fNIRS to record fluctuations in oxygenated and deoxygenated hemoglobin as a proxy for neural network activity in anemic patients. Researchers will map connectivity changes and highlight affected regions using heatmaps and arc-based visualizations. Participants are adults (18–65) with a diagnosis of anemia who are on their first hospitalization and able to give informed consent, with exclusions for psychiatric illness and severe brain disease. The goal is to link network abnormalities to cognitive symptoms to support earlier detection and targeted interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of anemia
* First hospitalization
* Male or female, aged 18-65 years
* Willing and able to comply with the requirements for this study and written informed consent

Exclusion Criteria:

* History of psychiatric illness
* History of severe brain disease
* Subjects that the investigator believes have other reasons that make them unsuitable for inclusion in this study

Where it's running

• Regenerative Medicine Center
  Tianjin, Tianjin Municipality, China Recruiting

Study contacts

• Study coordinator: ZheXiang Kuang, MSN
• Email: kuangzhexiang@ihcams.ac.cn
• Phone: 13920361752

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluation of diagnosis and treatment for autoimmune cytopenias

  This study is trying to understand how autoimmune cytopenias are diagnosed and treated, looking at different tests and treatments to see what works best for patients.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan · NCT05931718

• Exercise and NAD+ Supplementation for Young Cancer Survivors

  This study is testing if combining exercise with a supplement called nicotinamide riboside can help young cancer survivors improve their muscle strength and fitness.

  Recruiting at 3 sites Phase 2 Children's Hospital of Philadelphia · Duarte, California and 2 other locations · NCT05194397

• Transplanting umbilical cord blood from unrelated donors

  This study is testing different ways to prepare patients for umbilical cord blood stem cell transplants to see how safe and effective the procedure is for them.

  Recruiting University of Rochester · Rochester, New York · NCT03016806

• F182112 in relapsed/refractory autoimmune hemolytic anemia

  A small early study tests F182112 as a single treatment for adults with AIHA that has not responded to other therapies, to see if it’s safe and what dose works best.

  Recruiting Phase 1 Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT07816341

• Isatuximab in adults with refractory severe aplastic anemia

  This study tests whether the drug isatuximab can help adults with refractory severe aplastic anemia who have very low blood counts.

  Recruiting Phase 1/2 Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT07714512

• Age-stratified conditioning regimens to improve outcomes in haploidentical stem cell transplant for myelodysplastic syndrome

  This study tests two conditioning regimens in adults with MDS undergoing haploidentical stem cell transplant to see how age affects outcomes over one year.

  Recruiting Phase 2 Peking University People's Hospital · Beijing · NCT07677306

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.